Search results
How Are Biotech ETFs Reacting to These Q1 Earnings Releases?
Zacks via Yahoo Finance· 2 years agoThe Biotech sector has been in a tough spot for quite some time now. The Nasdaq Biotechnology Index...
Biotech Rebound Could Boost This ETF
ETF Trends via Yahoo Finance· 2 weeks agoBiotech stocks and the related exchange traded fund are in the midst of a lengthy run of disappointing investors. With the NASDAQ Biotechnology Index...
The Three Best Anti-Aging Stocks to Buy in September
InvestorPlace via Yahoo Finance· 2 years agoAnti-aging stocks have not proven immune to poor market conditions that have plagued the broader biotech industry. The biotech industry remains hampered...
3 Millionaire-Maker Biotech Stocks
Motley Fool via Yahoo Finance· 2 days agoIt's been a tough past three years for biotech stocks. Although the COVID-19 pandemic sparked bullish interest in the industry, this interest has waned...
‘Time to Pull the Trigger,’ Says Morgan Stanley About These 2 Healthcare Stocks
TipRanks via Yahoo Finance· 4 months agoIt’s been a bountiful year for the stock market but that doesn’t mean there haven’t been laggards....
Wager on WDNA for Biotech Rebound
ETF Trends via Yahoo Finance· 5 months agoIt’s been a lengthy of stretch of subpar performance by biotech stocks and related exchange traded funds. That’s a scenario that will repeat this year....
Is This the Green Light Biotech Stocks Have Been Waiting For?
Motley Fool· 8 months agoAre you a biotech investor who feels left behind? You're not alone. The broad Nasdaq Composite index...
Oppenheimer Says Biotech Stocks Look a Bit Brighter Right Now; Here Are 2 Names to Consider
TipRanks via Yahoo Finance· 2 years agoThe biotech sector, like most sections of the market, took a sound beating in the year’s first half....
Should You Invest in the iShares Biotechnology ETF (IBB)?
Zacks via Yahoo Finance· 11 months agoThe iShares Biotechnology ETF (IBB) was launched on 02/05/2001, and is a passively managed exchange...
2 Biotech Stocks That Could Soar in the Third Quarter
Motley Fool· 2 years agoCould a lousy, no-good, rotten year for biotech have a silver lining? It's hard to imagine the market's sentiment about innovative drugmakers getting worse than it already is. The Nasdaq Biotechnology ...
